In a case format, the speakers describe the advantages and limitations of molecular panels used for identification of pathogens and resistance markers from positive blood cultures.
True or False: Interpretation Challenges of Blood Culture Identification Panels
Susan Butler-Wu, PhD, LA County and USC Medical Center, Los Angeles, CA, USA
Pitfalls in Interpretation of Blood Culture Molecular ID Panels
Richard E. Davis, PhD, D(ABMM), MLS(ASCP)CM, Providence Sacred Heart Medical Center, Spokane, WA,
USA
Objectives:
- Understand the complexities and challenges associated with diagnosis and biomarker testing in small biopsy and cytology samples.
- Learn judicious ways to triage and optimize the use of small specimens for diagnostic and molecular/biomarker testing.
- Discuss approaches for optimal tissue collection and processing to maximize chances of ensuring successful
molecular testing in non small-cell lung cancer specimens.
Recording Date: November 19, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
